Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Development of CAR T Cells Targeting a Surface RNA-Binding Protein for the Treatment of Acute Leukemias. Local targets link to admitted publications; unresolved targets remain external evidence.
New directions for emerging therapies in acute myeloid leukemia: the next chapter
10.1038/s41408-020-00376-1 · 2020 · External reference
Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia
10.1016/j.cell.2018.05.013 · 2018 · External reference
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
10.1038/s41586-023-06496-5 · 2023 · External reference
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
10.1084/jem.20231235 · 2023 · External reference
Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia
10.1016/j.stem.2024.09.003 · 2024 · External reference
Selective haematological cancer eradication with preserved haematopoiesis
10.1038/s41586-024-07456-3 · 2024 · External reference
Cooperative CAR targeting to selectively eliminate AML and minimize escape
10.1016/j.ccell.2023.09.010 · 2023 · External reference
AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses
10.1182/blood-2017-02-768762 · 2018 · External reference
Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice
10.1182/bloodadvances.2017008342 · 2017 · External reference
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
10.1038/s43018-023-00656-2 · 2023 · External reference
Integrating Proteomics and transcriptomics for systematic combinatorial chimeric antigen receptor therapy of AML
10.1016/j.ccell.2017.09.004 · 2017 · External reference
Interferon-gamma promotes antibody-mediated fratricide of acute myeloid leukemia cells
10.1074/jbc.m116.753145 · 2016 · External reference
CD32C (Fc gamma RIIC) mRNA expression and regulation
10.1016/0161-5890(93)90149-6 · 1993 · External reference
Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system
10.1016/j.celrep.2018.04.051 · 2018 · External reference
Applying a clinical lens to animal models of CAR-T cell therapies
10.1016/j.omtm.2022.08.008 · 2022 · External reference
Transgenic expression of IL15 retains cd123-redirected T cells in a less differentiated state resulting in improved anti-AML activity in autologous AML PDX models
10.3389/fimmu.2022.880108 · 2022 · External reference
Novel classification system and high-risk categories of pediatric acute myeloid leukemia
10.3324/haematol.2024.285644 · 2025 · External reference
A new genomic framework to categorize pediatric acute myeloid leukemia
10.1038/s41588-023-01640-3 · 2024 · External reference
Developing a membrane-proximal CD33-targeting CAR T cell
10.1136/jitc-2024-009013 · 2024 · External reference
Augmentation of antitumor immunity by human and mouse CAR T cells secreting IL-18
10.1016/j.celrep.2017.09.002 · 2017 · External reference
Acute lymphoblastic leukemia, version 2.2024, NCCN clinical practice guidelines in Oncology
10.6004/jnccn.2024.0051 · 2024 · External reference
Mechanisms of resistance to CAR T cell therapy
10.1038/s41571-019-0184-6 · 2019 · External reference
RNA-binding proteins and glycoRNAs form domains on the cell surface for cell-penetrating peptide entry
10.1016/j.cell.2025.01.040 · 2025 · External reference
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein
10.1038/s41587-025-02648-2 · 2026 · External reference
Enhanced CAR T-cell therapy for lymphoma after previous failure
10.1056/nejmoa2408771 · 2025 · External reference
Memorial sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular Oncology
10.1016/j.jmoldx.2014.12.006 · 2015 · External reference
In vivo pharmacodynamic imaging of proteasome inhibition
10.2310/7290.2009.00007 · 2009 · External reference
Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics
10.1186/s13059-018-1603-1 · 2018 · External reference
Normalizing and denoising protein expression data from droplet-based single cell profiling
10.1038/s41467-022-29356-8 · 2022 · External reference
Dictionary learning for integrative, multimodal and scalable single-cell analysis
10.1038/s41587-023-01767-y · 2024 · External reference
Doublet identification in single-cell sequencing data using scDblFinder
10.12688/f1000research.73600.2 · 2021 · External reference
Assessing GPT-4 for cell type annotation in single-cell RNA-seq analysis
10.1038/s41592-024-02235-4 · 2024 · External reference
scGate: marker-based purification of cell types from heterogeneous single-cell RNA-seq datasets
10.1093/bioinformatics/btac141 · 2022 · External reference
clusterProfiler 4.0: a universal enrichment tool for interpreting omics data
10.1016/j.xinn.2021.100141 · 2021 · External reference
scRepertoire: an R-based toolkit for single-cell immune receptor analysis
10.12688/f1000research.22139.2 · 2020 · External reference
